Kazia Therapeutics - ADR Financials

$10.30

$-0.62 (-5.68%)

As on 23-Sep-2026 11:32EDT

Market cap

$119 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

4.9

Div. Yield

0 %

Annual
Quarterly

Income Statement (A$ Mln)	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Operating Revenue	0.04	2.31	0.00	0.01	15.18	0.99
Cost of Revenue	--	--	--	--	--	--
Gross Profit	0.04	2.31	0.00	0.01	15.18	0.99
Operating Expenses	14.26	30.77	24.12	25.41	21.56	13.18
Operating Profit (EBIT)	-14.22	-28.46	-24.12	-25.40	-6.38	-12.20
Other Income	--	--	--	--	--	--
Profit before Tax	-22.45	-27.05	-20.74	-25.38	-8.90	-12.77
Provision for Tax	-1.75	-0.27	-0.27	-0.37	-0.48	-0.30
Profit after Tax (Net Income)	-20.70	-26.78	-20.47	-25.01	-8.42	-12.47
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-20.47	-24.65	-8.42	-12.47

Liabilities (A$ Mln)	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Shareholder's Funds	-8.30	-10.02	12.05	18.28	37.85	14.13
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.31	5.81	8.47	10.89	11.91	3.87
Current Liabilities	14.05	25.80	7.57	6.73	8.33	5.07
Total Liabilities	6.06	21.59	28.08	35.89	58.09	23.06

Assets (A$ Mln)	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Non-Current Assets	1.13	15.44	17.31	26.44	28.70	12.41
Current Assets	4.93	6.15	10.77	9.45	29.39	10.65
Total Assets	6.06	21.59	28.08	35.89	58.09	23.06
Total Debt*	0.40	0.63	1.80	1.84	--	--
Net Current Assets	-9.12	-19.65	3.21	2.92	21.06	5.59

Cashflow (A$ Mln)	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Cash From Operating Activities	-13.28	-9.58	-15.16	-22.76	-9.11	-8.81
Cash Flow from Investing Activities	--	--	--	-2.37	-2.36	-2.36
Cash from Financing Activities	15.98	5.99	12.97	3.73	28.11	12.14
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Adjusted EPS (A$)	-24.35	-55.83	-0.09	-0.17	--	-0.90
Cash EPS (A$)	-23.25	-51.94	-0.08	-0.16	--	-0.83
Adjusted Book Value (A$)	--	--	0.05	0.13	--	1.02
Dividend per Share (A$)	--	--	--	--	--	--
Cash Flow per Share (A$)	-15.62	-19.98	-0.06	-0.16	--	-0.64
Free Cash Flow per Share (A$)	-15.62	-19.98	-0.06	-0.16	--	-0.64

Profitability Ratios	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
ROCE (%)	239.50	-1,200.00	-120.52	-86.30	-32.40	-88.05
ROE (%)	226.03	-2,634.33	-134.97	-89.14	-32.40	-88.05
ROA (%)	-149.76	-107.83	-63.98	-53.23	-20.75	-56.36
EBIT Margin (%)	-33,850.00	-1,233.19	-4,350,725.59	-253,840.00	-41.99	-1,234.06
Net Margin (%)	-49,290.48	-1,160.23	-3,687,419.82	-250,140.00	-55.46	-1,261.75
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Revenue Growth (%)	-0.98	4,157.56	-0.94	-1.00	14.37	630.38
EBIT Growth (%)	50.05	-17.87	4.88	-298.12	47.71	-38.64
Net Profit Growth (%)	22.69	-30.85	18.19	-197.08	32.46	-21.40
EPS Growth (%)	0.56	-643.78	0.50	--	--	-28.85
Book Value Growth (%)	--	--	--	--	--	--

Solvency Ratios	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Debt to Equity	-0.05	-0.06	0.15	0.10	--	--
Short term debt to equity ratio	-0.05	-0.06	0.15	0.10	--	--
Current Ratio	0.35	0.24	1.42	1.40	3.53	2.10
Quick Ratio	--	--	1.93	--	3.54	2.10
Interest Coverage	--	--	--	-12,122.25	-1.25	-50.81

Operating Efficiency Ratios	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15
Debtors to sales (%)	214.29	5.76	18,918.92	510.00	0.50	0.04
Asset Turnover	0.00	0.09	0.00	0.00	0.37	0.04
Receivable days	969.65	18.83	51,332.43	2,319.34	0.92	287.96
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--